Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI Nifty IT ETF · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

UTI Nifty IT ETFNippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseUTINippon India
NAV₹330.7264₹29.1863
NAV date20 Nov 202620 Nov 2026
History2.8 years5.4 years
Expense ratio0.0%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

UTI Nifty IT ETFNippon India Nifty Pharma ETF
1 month−0.48%+10.82%
3 months+2.45%+7.43%
6 months+8.33%+14.54%
YTD−15.96%+25.40%
1 year−14.01%+25.57%
3 years (CAGR)—+22.02%
5 years (CAGR)—+16.60%
10 years (CAGR)——
Since launch−3.60%+14.02%

Risk

UTI Nifty IT ETFNippon India Nifty Pharma ETF
Volatility—15.0%
Downside volatility—9.0%
Sharpe—1.04
Sortino—1.72
Calmar—1.33
Return / risk—1.47
Deepest fall−42.03%−20.98%
Days to recover—136
Below its high−29.14%−1.75%

Against benchmark

UTI Nifty IT ETFNippon India Nifty Pharma ETF
Alpha—+0.00%
Beta—1.00
R²—100.0%
Up capture—100.0%
Down capture—100.0%
Tracking error—0.0%
Information ratio——
Treynor—0.14

Consistency

UTI Nifty IT ETFNippon India Nifty Pharma ETF
Best 1-year+19.08%+65.21%
Middle 1-year−11.22%+13.46%
Worst 1-year−32.16%−15.30%
1-year periods with a loss77.0%25.8%
Middle 3-year—+20.51%
Positive months—61.1%
Best day+6.69%+3.64%
Worst day−5.86%−4.03%
Worst 5% day−2.19%−1.62%
Positive days48.2%54.4%
NAVs a year248248

SIP of ₹10,000 a month

UTI Nifty IT ETFNippon India Nifty Pharma ETF
5-year XIRR—+20.60%
5-year value—₹10,11,738
3-year XIRR—+19.58%
1-year XIRR−0.25%+34.31%

Holdings overlap i

UTI Nifty IT ETFNippon India Nifty Pharma ETF
UTI Nifty IT ETF—0%
Nippon India Nifty Pharma ETF0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

UTI Nifty IT ETFNippon India Nifty Pharma ETF
Large companies81.7%45.3%
Mid companies17.8%47.1%
Small companies—7.6%
Top 10 holdings99.5%78.6%
Largest sectorIT - Software 100%Pharmaceuticals & Biotechnology 100%

Search Growth